Fulgent Genetics
FLGT | NASDAQ
$24.07
-$0.59 (-2.39%)
At close: Nov 16, 2026, 4:00 PM ET
$24.07
$0.00 (+0.02%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-2.39%
(1D)No price chart data available for 1D timeframe.
Rating
33.8
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #688/1021 (Top 67%)
Key Statistics
Market Data
Market Cap $672.63M
1D Range
23.88 24.47
52W Range
13.79 30.85
Valuation (TTM)
PE -7.79
PB 0.68
EV/EBITDA -0.27
Valuation (NTM)
Forward PE N/A
Forward PEG 0.01
Price Target $19.00
Cash Flow
FCF Yield -0.2%
SBC Adj. FCF Yield -5.5%
SBC Impact -2565.0%
Margins
Gross Margin 33.8%
Operating Margin -35.8%
FCF Margin -0.4%
Growth (CAGR)
Revenue 3Y | 5Y 4.9% |
-20.4%
Dil EPS 3Y | 5Y 36.5% |
-332.6%
FCF 3Y | 5Y 81.9% |
-120.3%
Returns
ROA -8.4%
ROE -8.8%
ROIC -11.7%
Financial Health
Net Cash
$651.81M
Current Ratio 5.34
Interest Coverage -586.67
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Fulgent Genetics, Inc., together with its affiliated companies, offers a comprehensive suite of COVID-19, molecular diagnostic, and genetic testing services to healthcare providers and individuals glo...
Sector Healthcare
Industry Medical - Diagnostics & Research
Employees 1,315
IPO Date Sep 29, 2016
Website www.fulgentgenetics.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 5, 2026
EPS
-$0.09
Beat +86.15%
YoY:
-164.29% REV
$90.41M
Beat +4.76%
YoY:
+7.54%Next Earnings
Feb 26, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
1
Consensus
Hold
Price Target
$19.00
Downside
-21.06%
Buy (0)
Hold (1)
Sell (0)
Add to Watchlist
Select watchlists to add or remove FLGT